Cargando…

During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

SIMPLE SUMMARY: Hepatitis C virus (HCV) therapy lowers risk of liver cancer. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) regulate immune response and pathogenesis of disease. We evaluated soluble markers of interferon signaling and liver cirrhosis, plasma miRNAs and other non-coding RNAs t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damjanovska, Sofi, Alao, Hawwa, Zebrowski, Elizabeth, Kowal, Corinne, Kostadinova, Lenche, Davitkov, Perica, Falck-Ytter, Yngve, Shive, Carey L., Cartwright, Michael, Richardson, Brian, Wald, David, Cameron, Mark, Valadkhan, Saba, Anthony, Donald D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495750/ https://www.ncbi.nlm.nih.gov/pubmed/36138741 http://dx.doi.org/10.3390/biology11091262

Ejemplares similares

High Red Cell Distribution Width and Low Absolute Lymphocyte Count Associate With Subsequent Mortality in HCV Infection
por: Damjanovska, Sofi, et al.
Publicado: (2021)

Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of direct-acting antiviral therapy
por: Auma, Ann W. N., et al.
Publicado: (2022)

Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy
por: Kostadinova, Lenche, et al.
Publicado: (2018)

Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy
por: Reyes-Avilés, Elane, et al.
Publicado: (2015)

Endotoxemia Associated with Liver Disease Correlates with Systemic Inflammation and T Cell Exhaustion in Hepatitis C Virus Infection
por: Shive, Carey L., et al.
Publicado: (2023)

Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation
por: Kostadinova, Lenche, et al.
Publicado: (2019)

Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease–A population-based study
por: Davitkov, Perica, et al.
Publicado: (2023)

Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
por: Damjanovska, Sofi, et al.
Publicado: (2022)

Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection
por: Auma, Ann W. N., et al.
Publicado: (2021)

Regulation of Interferon-Stimulated Gene BST2 by a lncRNA Transcribed from a Shared Bidirectional Promoter
por: Kambara, Hiroto, et al.
Publicado: (2015)

Spotlight: COVID-19 PPE and Endoscopy
por: Siddique, Shazia M., et al.
Publicado: (2020)

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic
por: Sultan, Shahnaz, et al.
Publicado: (2020)

Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons
por: Auma, Ann W.N., et al.
Publicado: (2021)

Evidence-Based Cognitive Endoscopy Simulators: Do They Exist? A Systematic Search and Evaluation of Existing Platforms
por: Shah, Raj, et al.
Publicado: (2022)

Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C
por: Davitkov, Perica, et al.
Publicado: (2016)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
por: Sultan, Shahnaz, et al.
Publicado: (2020)

AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update
por: Sultan, Shahnaz, et al.
Publicado: (2021)

Providing Timely, Trustworthy Guidance to Frontline Clinicians during a Pandemic
por: Falck-Ytter, Yngve, et al.
Publicado: (2021)

Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10
por: Chu, Hongxing, et al.
Publicado: (2017)

Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta‐analysis
por: Bohn, Emma, et al.
Publicado: (2021)

Negative regulation of the interferon response by an interferon-induced long non-coding RNA
por: Kambara, Hiroto, et al.
Publicado: (2014)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

A case study of a real-time evaluation of the risk of disease transmission associated with a failure to follow recommended sterilization procedures
por: Donskey, Curtis J, et al.
Publicado: (2014)

Longitudinal high-risk sibling studies of autism spectrum disorder
por: Falck-Ytter, Terje
Publicado: (2012)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Hosui, Atsushi, et al.
Publicado: (2021)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs
por: Ponnuvel, Suresh, et al.
Publicado: (2023)

See MIPS Run
por: Sweetman, Dominic
Publicado: (2006)

The MIP Timing Detector
por: CMS Collaboration
Publicado: (2019)

HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics
por: Chehl, Navdeep, et al.
Publicado: (2019)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
por: Maughan, A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_upr3iem054k6ugiuuhj84k3ucs